These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 24085550

  • 1. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F, de Carvalho Bittencourt M, Rat AC, Loeuille D, Dintinger H, Béné MC, Faure G, Chary-Valckenaere I.
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [Abstract] [Full Text] [Related]

  • 2. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [Abstract] [Full Text] [Related]

  • 3. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z, Lovasz BD, Gecse KB, Balint A, Farkas K, Morocza-Szabo A, Gyurcsanyi A, Kristof K, Vegh Z, Gonczi L, Kiss LS, Golovics PA, Lakatos L, Molnar T, Lakatos PL.
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [Abstract] [Full Text] [Related]

  • 4. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H, Kim YW, Suh CH, Jung JY, Um YJ, Jung JH, Kim HA.
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H, Yuen CS, Yip RM.
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [Abstract] [Full Text] [Related]

  • 6. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [Abstract] [Full Text] [Related]

  • 7. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S, Tony HP, Krueger K, Detert J, Mielke F, Rockwitz K, Schwenke R, Burmester GR, Diel R, Feuchtenberger M, Kneitz C.
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis.
    Song GG, Bae SC, Lee YH.
    Int J Rheum Dis; 2013 Jun; 16(3):279-83. PubMed ID: 23981748
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS.
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [Abstract] [Full Text] [Related]

  • 10. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S.
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [Abstract] [Full Text] [Related]

  • 11. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X, Baron G, Tubach F, Lioté F, Combe B, Miceli-Richard C, Flipo RM, Goupille P, Allez M, Salmon D, Emilie D, Carcelain G, Ravaud P.
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [Abstract] [Full Text] [Related]

  • 12. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J, Sá R, Cardoso MJ, Silva R, Ferreira J, Ribeiro C, Miranda M, Plácido JL, Nienhaus A.
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [Abstract] [Full Text] [Related]

  • 13. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB, da Mota NVF, Salles MJC, Burattini MN, Rodrigues DS.
    BMC Infect Dis; 2018 Nov 19; 18(1):585. PubMed ID: 30453903
    [Abstract] [Full Text] [Related]

  • 14. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
    Wolf T, Goetsch U, Oremek G, Bickel M, Khaykin P, Haberl A, Bellinger O, Gottschalk R, Brodt HR, Stephan C.
    J Infect; 2013 Apr 19; 66(4):376-80. PubMed ID: 23159357
    [Abstract] [Full Text] [Related]

  • 15. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A, Toprak D, Koc M, Arikan H, Akoglu E, Bakir M.
    Nephrol Dial Transplant; 2012 Apr 19; 27(4):1645-50. PubMed ID: 21931124
    [Abstract] [Full Text] [Related]

  • 16. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.
    Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H.
    J Rheumatol; 2009 Dec 19; 36(12):2675-81. PubMed ID: 19918035
    [Abstract] [Full Text] [Related]

  • 17. Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases.
    Pyo J, Cho SK, Kim D, Sung YK.
    Korean J Intern Med; 2018 Nov 19; 33(6):1241-1251. PubMed ID: 29277097
    [Abstract] [Full Text] [Related]

  • 18. Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.
    Chang B, Park HY, Jeon K, Ahn JK, Cha HS, Koh EM, Kang ES, Koh WJ.
    Clin Rheumatol; 2011 Dec 19; 30(12):1535-41. PubMed ID: 21556777
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH, Won S, Choi CB, Sung YK, Song GG, Bae SC.
    Int J Rheum Dis; 2015 Mar 19; 18(3):315-22. PubMed ID: 25351815
    [Abstract] [Full Text] [Related]

  • 20. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH, Seo GY, Lee JS, Kim TH, Yoo DH.
    J Rheumatol; 2009 Oct 19; 36(10):2158-63. PubMed ID: 19723901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.